Abstract
Beta-ketothiolase (mitochondrial acetoacetyl-CoA thiolase) deficiency is a genetic disorder characterized by impaired isoleucine catabolism and ketone body utilization that predisposes to episodic ketoacidosis. It results from biallelic pathogenic variants in the ACAT1 gene, encoding mitochondrial beta-ketothiolase. We report two cases of beta-ketothiolase deficiency presenting with acute ketoacidosis and “metabolic stroke.” The first patient presented at 28 months of age with metabolic acidosis and pallidal stroke in the setting of a febrile gastrointestinal illness. Although 2-methyl-3-hydroxybutyric acid and trace quantities of tiglylglycine were present in urine, a diagnosis of glutaric acidemia type I was initially suspected due to the presence of glutaric and 3-hydroxyglutaric acids. A diagnosis of beta-ketothiolase deficiency was ultimately made through whole exome sequencing which revealed compound heterozygous variants in ACAT1. Fibroblast studies for beta-ketothiolase enzyme activity were confirmatory. The second patient presented at 6 months of age with ketoacidosis, and was found to have elevations of urinary 2-methyl-3-hydroxybutyric acid, 2-methylacetoacetic acid, and tiglylglycine. Sequencing of ACAT1 demonstrated compound heterozygous presumed causative variants. The patient exhibited choreoathethosis 2 months after the acute metabolic decompensation. These cases highlight that, similar to a number of other organic acidemias and mitochondrial disorders, beta-ketothiolase deficiency can present with metabolic stroke. They also illustrate the variability in clinical presentation, imaging, and biochemical evaluation that make screening for and diagnosis of this rare disorder challenging, and further demonstrate the value of whole exome sequencing in the diagnosis of metabolic disorders.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Abdelkreem E, Otsuka H, Sasai H et al (2016) Beta-ketothiolase deficiency: resolving challenges in diagnosis. J Inborn Errors Metab Screen 4:1–9
Akella RRD, Aoyama C, Mori C, Lingappa L, Cariappa R, Fukao T (2014) Metabolic encephalopathy in beta-ketothiolase deficiency: the first report from India. Brain Dev 36:537–540
Buhas D, Bernard G, Fukao T, Decarie JC, Chouinard S, Mitchell GA (2013) A treatable new cause of chorea: beta-ketothiolase deficiency. Mov Disord 28:1054–1056
Catanzano F, Ombrone D, Di Stefano C et al (2010) The first case of mitochondrial acetoacetyl-CoA thiolase deficiency identified by expanded newborn metabolic screening in Italy: the importance of an integrated diagnostic approach. J Inherit Metab Dis 33:91
Cazorla MR, Verdu A, Perez-Cerda C, Ribes A (2007) Neuroimage findings in 2-methyl-3-hydroxybutytyl-CoA dehydrogenase deficiency. Pediatr Neurol 36:264–267
Daum RS, Lamm PH, Mamer OA, Scriver CR (1971) A “new” disorder of isoleucine catabolism. Lancet 2:1289–1290
Estrella J, Wilcken B, Carpenter K, Bhattacharya K, Tchan M, Wiley V (2014) Expanded newborn screening in New South Wales: missed cases. J Inherit Metab Dis 37:881–887
Frazier DM, Millington DS, McCandless SE et al (2006) The tandem mass spectrometry newborn screening experience in North Carolina: 1997-2005. J Inherit Metab Dis 29:76–85
Fukao T, Yamaguchi S, Orii T, Osumi T, Hashimoto T (1992a) Molecular basis of 3-ketothiolase deficiency: identification of an AG to AC substitution at the splice acceptor site of intron 10 causing exon 11 skipping. Biochim Biophys Acta 1139:184–188
Fukao T, Yamaguchi S, Orii T, Schutgens RB, Osumi T, Hashimoto T (1992b) Identification of three mutant alleles of the gene for mitochondrial acetoacetyl-coenzyme A thiolase. A complete analysis of two generations of a family with 3-ketothiolase deficiency. J Clin Invest 89:474–479
Fukao T, Zhang GX, Sakura N et al (2003) The mitochondrial acetoacetyl-CoA thiolase (T2) deficiency in Japanese patients: urinary organic acid and blood acylcarnitine profiles under stable conditions have subtle abnormalities in T2-deficient patients with some residual T2 activity. J Inherit Metab Dis 26:423–431
Fukao T, Maruyama S, Ohura T et al (2012) Three Japanese patients with beta-ketothiolase deficiency who share a mutation, C.431A>C (H144P) in ACAT1: subtle abnormality in urinary organic acid analysis and blood acylcarnitine analysis using tandem mass spectrometry. JIMD Reports 3:107–115
Fukao T, Mitchell G, Sass JO, Hori T, Orii K, Aoyama Y (2014) Ketone body metabolism and its defects. J Inherit Metab Dis 37:541–551
Hillman RE, Keating JP (1974) Beta-ketothiolase deficiency as a cause of the “ketotic hyperglycinemia syndrome”. Pediatrics 53:221–225
Korman SH (2006) Inborn errors of isoleucine degradation: a review. Mol Genet Metab 89:289–299
Lek M (2016) Analysis of protein-coding genetic variation in 60,706 humans. Nature 536:285–291
Marquardt G, Currier R, McHugh DM et al (2012) Enhanced interpretation of newborn screening results without analyte cutoff values. Genet Med 14:648–655
Middleton B, Bartlett K (1983) The synthesis and characterisation of 2-methylacetoacetyl coenzyme A and its use in the identification of the site of the defect in 2-methylacetoacetic and 2-methyl-3-hydroxybutyric aciduria. Clin Chim Acta 128:291–305
O’Neill ML, Kuo F, Saigal G (2014) MRI of pallidal involvement in beta-ketothiolase deficiency. J Neuroimaging 24:414–417
Ozand PT, Rashed M, Gascon GG et al (1994) 3-Ketothiolase deficiency: a review and four new patients with neurologic symptoms. Brain Dev 16:38–45
Sarafoglou K, Matern D, Redlinger-Grosse K et al (2011) Siblings with mitochondrial acetoacetyl-CoA thiolase deficiency not identified by newborn screening. Pediatrics 128:e246–e250
Shiasi Arani K, Soltani B (2014) First report of 3-oxothiolase deficiency in Iran. Int J Endocrinol Metab 12:e10960
Yalcinkaya C, Apaydin H, Ozekmekci S, Gibson KM (2001) Delayed-onset dystonia associated with 3-oxothiolase deficiency. Mov Disord 16:372–375
Zschocke J (2012) HSD10 disease: clinical consequences of mutations in the HSD17B10 gene. J Inherit Metab Dis 25:81–89
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Additional information
Communicated by: Frits Wijburg
Appendices
Synopsis
Beta-ketothiolase deficiency, causing episodic, severe ketoacidosis, can present with metabolic stroke and may be difficult to diagnose biochemically.
Monica H. Wojcik conceptualized this case report, contributed to the writing of the manuscript, and provided clinical care for one of the patients reported.
Klaas J. Wierenga provided clinical care for one of the patients reported and contributed to the writing of the manuscript.
Lance H. Rodan provided clinical care for one of the patients reported and contributed to the writing of the manuscript.
Inderneel Sahai performed the newborn screen analysis for one of the patients reported and critically reviewed the manuscript.
Sacha Ferdinandusse performed the fibroblast enzyme assay for one of the patients reported and critically reviewed the manuscript.
Casie A. Genetti contributed to the whole exome sequencing for one of the patients reported.
Meghan C. Towne contributed to the whole exome sequencing for one of the patients reported.
Roy W.A. Peake aided in the biochemical laboratory interpretation for one of the patients reported and critically reviewed the manuscript.
Philip James provided clinical care for one of the patients reported and critically reviewed the manuscript.
Alan H. Beggs contributed to the whole exome sequencing for one of the patients reported and critically reviewed the manuscript.
Catherine A. Brownstein contributed to the whole exome sequencing for one of the patients reported.
Gerard T. Berry provided clinical care for one of the patients reported and critically reviewed the manuscript.
Pankaj B. Agrawal conceptualized this case report, contributed to the whole exome sequencing for one of the patients reported, and contributed to the writing of the manuscript.
Corresponding Author
Pankaj B. Agrawal, who serves as guarantor for the chapter, accepts full responsibility for the work, had access to the data, and controlled the decision to publish.
Competing Interests
No competing interests are reported by the authors.
Funding
MHW is supported by training grant T32 HD07466 through the National Institutes of Health (NIH). PBA was supported by R01 AR068429 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the NIH and U19 HD077671 from the National Institute of Child Health and Human Development/National Human Genome Research Institute/NIH. The Gene Discovery Core of The Manton Center for Orphan Disease Research, Boston Children’s Hospital also supported the work. Whole exome sequencing was performed by the Yale Center for Mendelian Genomics, supported by NIH grant 2UM1HG006504. Sanger sequencing was performed by the Molecular Genetics Core Facility of the Intellectual and Developmental Disabilities Research Center (IDDRC) at Boston Children’s Hospital, supported by NIH grant U54 HD090255.
Ethics Approval
As these are retrospective case reports, approval by an Institutional Review Board was not required. Patient one and the patient’s parents had whole exome sequencing performed on a research basis through an IRB-approved protocol with the Manton Center for Orphan Disease Research at Boston Children’s Hospital.
Patient Consent Statement
As these are retrospective case reports without identifiable information, patient consent was not obtained.
Rights and permissions
Copyright information
© 2017 SSIEM and Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Wojcik, M.H. et al. (2017). Beta-Ketothiolase Deficiency Presenting with Metabolic Stroke After a Normal Newborn Screen in Two Individuals. In: Morava, E., Baumgartner, M., Patterson, M., Rahman, S., Zschocke, J., Peters, V. (eds) JIMD Reports, Volume 39. JIMD Reports, vol 39. Springer, Berlin, Heidelberg. https://doi.org/10.1007/8904_2017_45
Download citation
DOI: https://doi.org/10.1007/8904_2017_45
Received:
Revised:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-57576-5
Online ISBN: 978-3-662-57577-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)